MULTI-EPITOPISCHES KONSTRUKT

European patent · EP3250584 · In force

Register entry

Publication number
EP3250584
Application number
EP16701871
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 25, 2016
Published
Dec 6, 2017
Granted
May 12, 2021
Protection ends at the latest
Jan 24, 2036
Next annual fee due
Jan 31, 2027
IPC classes
C07K 14/195 (2006.01)
A61K 39/385 (2006.01)
C07K 14/35 (2006.01)
Priority
GB 201501354 27.01.2015
GB 201510195 11.06.2015
PCT application
PCT/GB2016/050150 25.01.2016
PCT publication
WO2016/120596 04.08.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 11, 2026

    Change

    Published in Swissreg on 11.02.2026

  2. Feb 19, 2025

    Change

    Published in Swissreg on 19.02.2025

  3. Feb 5, 2024

    Change

    Published in Swissreg on 05.02.2024

  4. Feb 2, 2023

    Change

    Published in Swissreg on 02.02.2023

  5. Mar 23, 2022

    Change

    Published in Swissreg on 23.03.2022

  6. May 26, 2021

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 26.05.2021

  7. May 12, 2021

    Granted

    Published in Swissreg on 12.05.2021

Parties

Holder

Thrombosis Research Institute

Emmanuel Kaye Building 1 Manresa Road Chelsea, Greater London SW3 6LR, GB

Agent

HGF GmbH

OBC Suisse AG Aeschengraben 29, 4051 Basel

Inventor

KAKKAR, Vijay

London SW3 6LR, GB

LU, Xinjie

London SW3 6LR, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.